Amid the opioid crisis at home, the United States wastes millions on questionable Afghan drug treatment programs. Worse they haven’t a clue if these programs are even working! Uncle Sam spent $50.5 million on dozens of drug treatment programs between 2013 and 2018. The treatment projects are implemented by the United Nations on Drugs. A report published by the Special Inspector General for Afghanistan Reconstruction (SIGAR) slams the government for failing to monitor the performance of its drug addiction projects in Afghanistan, writing that the State Department  “does not know the impact to date of its investment.” The State Department didn’t even bother to conduct site visits to project locations and failed to maintain files or records required under agency rules. 

While millions are wasted in overseas drug programs, the focus on the opioid drug crisis back home continues to escalate. Federal and state governments are inviting in criminal alien drug traffickers, protecting them with sanctuary cities, releasing hardened traffickers of illicit drugs from prison, and then attacking doctors and pain patients who prescribe and consume legitimate pain medication.

With all the media exposure and public awareness, will doctors be afraid to prescribe pain meds now? What kind of an impact will this have on the healthcare industry? Both the CDC and the Food and Drug Administration (FDA) warned doctors in April 2019, not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic debilitating pain, generally lasting more than three months. Will the medical industry adhere to that recommendation from the CDC and FDA? 

Michael Johns is the National co-founder and leader of the Tea Party Movement. A former White House speechwriter and a Policy Analyst with The Heritage Foundation. Dr. Ron Martinelli, is a retired police detective, a forensic criminologist, and a national voice known as the “expert’s expert.”

Subscribe to
THE VOICE OF A NATION

Or subscribe with your favorite app by using the address below